Pfizer Set to Acquire Metsera in $10 Billion Deal
Pharmaceutical giant Pfizer is set to finalize the acquisition of Metsera, a U.S.-based biotechnology company specializing in obesity treatments, after outbidding Danish rival Novo Nordisk in a high-stakes takeover battle. Metsera’s board announced on Friday that it had unanimously approved Pfizer’s improved offer of up to $86.25 per share, valuing the deal at around $10…
